• What is ReMedIs
  • Welcome
  • Conference venue and accomodation
• Scientific Program
  • Abstract Submission
  • Advisory Board
  • Keynote speakers
    • George Plopper
    • Hari Shanker Sharma
    • Hitoshi Okamura
    • Iulian Antoniac
    • Jill Urban
    • Krishna Pramanik
    • Kyung-Sun Kang
    • Sunil Kumar Sarangi
    • Thomas J. Webster
  • Main Topics
  • Scientific Program
  • Statements
• Participants
  • Accommodation
  • Links
  • Registration
  • Registration fees
• Sponsoring
  • Endorsing Partners
  • Media Partners
  • Sponsors

ENDORSED by

Home

Regenerative medicine, branch of advanced medical therapies (together with nanomedicine and personalized therapies), is a rapidly growing multidisciplinary field involving the life, physical and engineering sciences that seeks to develop functional cell, tissue, and organ substitutes in order to restore  anatomy and function that  has been lost due to congenital abnormalities, injury, disease, or ageing. With regenerative medicine this is prospected to be done through a variety of approaches including the replacement of tissue function with synthetic constructs (engineered tissues or organs) and using cellular therapies such as stem cells or genetically modified cells to generate new tissues and organs.

Current  available therapeutic methods, reconstructive surgery, tissue and organ transplantation offer valuable solutions for a large panel of pathological conditions. They still have clinical limitations. Medical devices cannot complexly substitute the biological function and will eventually deteriorate with time. Facing increasing needs for tissue and organ replacements due to trauma or degenerative conditions, there is a shortage of available donors rising ethical debates over waiting lists priorities and organ harvesting protocols.

Not only regenerative medicine is to offer valuable solutions for addressing these issues, but it is also to be sought as revolutionary concept in health care. Regenerating, replacing, enhancing anatomy and or function is to be done either by using natural body capacity of healing, inducing in vivo regeneration either by ex vivo generating functional tissues and  organs closely similar to original ones.

While there is a promising  body of research in the field of cell biology, biomaterials, biotechnologies, regenerative medicine products are still waiting for their era of clinical extensive application.

Though still in early stages, regenerative medicine has already provided efficient solutions for tissue transplantation (skin, bone, cartilage). It has been stated that application of regenerative medicine is the most promising tool for improving health in developing countries facing the challenge of increasing rates of noncomunicable diseases.

Acknowledging advanced medicine potential, Romania is one of the 14 contributing members of REMEDIC (regenerative medicine) project launched by European Science Foundation, aiming to initiate a cross disciplinary research networking programme for the advancement of research, translational and clinical application in the field.

REMEDIS Iasi 15/18 July 2010 is intended to offer the chance for researchers, biotechnology companies representative, clinicians to interact in a highly scientific but friendly environment.

Part of AT-EQUAL (advanced technologies for improving quality of life), REMEDIS 2010 is adding biotechnology to the panel of cutting edge scientific solutions in assisting health, rehabilitation and human dignity recovery.

Mark your calendar

REMEDIS IASI ROMANIA 15-18  July 2010

Regenerating,restoring,enhancing,human bodily parts based on natural laws of growth and development

Join us in Iasi, midsummer,  2010 for a interdisciplinary multicultural approach in regenerative medicine.